Johnson & Johnson in talks to buy Dutch biotech firm Crucell for $2.29 billion

Johnson & Johnson plans to buy Crucell for $2.3B)

Suriname’s new president back in power after weeklong illness; confirms had dengue

Dengue
more images

Anxiety ridden heart patients face higher death risk

heart stroke

AP answers your questions on the news, from sex addiction treatments to the Toyota recall

Ask AP: Sex addiction, the Toyota recall

Now that sex addiction has found its poster child in Tiger Woods, more people are familiar with the affliction. Yet how it’s treated remains a mystery to many.

Dutch group pushing for right to suicide for people older than 70 gains support

Dutch group endorses right to suicide for elderly

Dutch fashion designer Edgar Vos, who dressed stars and royals, dies at age 78

heart attacks

Studies: Switching antiseptic prep, screening patients for bacteria cut post-op infections

Antibiotics
more images

Johnson & Johnson takes 18 percent stake in Crucell for euro301.8 million

Johnson & Johnson buys 18 percent stake in Crucell

AMSTERDAM — U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in biotechnology company Crucell NV for €301.8 million ($440 million), the Dutch company said in a statement Monday.

Research shows statin use reduces heart attacks, deaths after surgery on blood vessels

Statin cuts heart problems after artery surgery

NEW YORK — Score another victory for the cheap, cholesterol-lowering wonder drugs known as statins. People getting an artery unclogged or repaired were much less likely to die or have a heart attack afterward if they took preventive doses of the pills before and after their operations, a Dutch study showed.

Protected by Comment Guard Pro